Successful treatment of pityriasis rubra pilaris with guselkumab: Serum CCL20 as a potential marker for the disease activity.
Dermatologic therapy（2020）
Key words
CCL20,guselkumab,interleukin-17,interleukin-23,pityriasis rubra pilaris
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined